In recent years, shortages of immunoglobulins (Ig) have become a growing concern in the European Union (EU).

EHA welcomes the European Parliament’s backing for SoHO legislation that puts patient safety and supply sustainability first.

The issue of immunoglobulin shortages and the importance of enhancing and maintaining plasma supplies have gained significant attention within the policy and regulatory landscape of the European Union.

EHA to participate in an EU-funded project on “Strengthening voluntary non-remunerated plasma collection capacity in Europe” (SUPPLY) Context: Plasma shortage  Plasma-derived medicinal products (PDMPs) are used to treat a variety of rare,…